Pasar al contenido principal

ANALISIS DEL PAPEL DE LAS NEURONAS KNDY Y SISTEMAS CENTRALES RELACIONADOS EN EL CONTROL DE LA PUBERTAD Y SUS ALTERACIONES EN CONDICIONES DE OBESIDAD DE INICIO TEMPRANO

PID2023-149244NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE CORDOBA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Cannabidiol improves metabolic profiles and alleviates liver inflammation and fibrosis in conditions of androgenic obesity and polycystic ovary syndrome

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microglia Rank signaling regulates GnRH neuronal function and the hypothalamic-pituitary-gonadal axis

  • Collado-Sole, Alejandro
  • Borjini, Nozha
  • Zhai, Jing
  • Ruiz-Pino, Francisco
  • Soria-Alcaide, Gonzalo
  • Folgueira, Cintia
  • García-Vilela, Celia
  • Romero-de la Rosa, Beatriz
  • López, Víctor
  • Zouaghi, Yassine
  • Jacobs, An
  • Mora-Romero, Bella
  • Barranco, Alexandra
  • Yoldi, Guillermo
  • Rizzoti, Karine
  • Sabio, Guadalupe
  • Pérez-Chacón, Gema
  • Santamaría, Patricia G.
  • Esteban, José Antonio
  • Journiac, Nathalie
  • Prevot, Vincent
  • Pascual Bravo, Alberto
  • Fernández-Chacón, Rafael
  • Tena-Sempere, Manuel
  • Pitteloud, Nelly
  • González-Suárez, Eva
[Data, code, and materials availability] The scRNA-seq results obtained in this work have been deposited at Gene Expression Omnibus, GSE240379. Mouse strains used in this study are subject to a Material Transfer Agreement and can be shared upon reasonable request and in accordance with the corresponding institutional regulations. The rest of the data used in the preparation of the manuscript are available in the main text or in the supplementary materials., The hypothalamic-pituitary-gonadal axis (HPG) controls pubertal development, sexual maturation, and fertility. We identified a role of hypothalamic microglia in controlling the HPG axis through receptor activator of nuclear factor κB (Rank) signaling. Whole-body and microglia Rank (mouse) depletion led to hypogonadotropic hypogonadism (HH) resulting from an alteration in gonadotropin-releasing hormone (GnRH) neuron function. In addition, we identified rare gene variants of RANK (human) in patients with HH. Transcriptional profiling upon Rank loss revealed defective microglia activation and morphological alterations in the median eminence, decreasing the contacts and engulfment of GnRH terminal projections and impairing GnRH neuronal responses to kisspeptin. Overall, our data uncover the microglia as regulator of GnRH neuronal function through Rank signaling, with potential implications for reproductive maturation and fertility., This work was supported by grants from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 682935, EGS); CaixaResearch Health 2023 grants from the “la Caixa” Foundation (no. HR23-00361, EGS); Comunidad Autónoma de Madrid S2022/BMD-7393 (EGS) and the Spanish Ministry of Science and Innovation through the Agencia Estatal de Investigación (AEI) (SAF2017-86117-R, PID2020-116441GB-I00, and PID2023-152798OB-I00; EGS), cofunded by FEDER/European Regional Development Fund (ERDF) (“A way to build Europe”). Grant PID2023-149244NB-I00 was awarded to M.T.-S. Additional support was provided by the Spanish Agencia Estatal de Investigación and the Ministerio de Ciencia, Innovación y Universidades, and the European Regional Development Fund (ERDF) (MICIU/AEI/10.13039/501100011033; FEDER, UE) through project PID2022-138957NB-I00 (R.F.-C.) as well as by the Plan Propio de Investigación de la Universidad de Sevilla, Contrato Acción II.4 PPIT (N.B.). A.C.-S. was supported by an FPU fellowship (FPU2018/00546), and A.B. was supported by an FPI fellowship (PRE2018-086522). C.F. was supported by a Miguel Servet contract (CP24_00036) from the Instituto de Salud Carlos III (ISCIII). A.C.-S. also received an EACR travel grant (EACR-907), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery and pharmacological evaluation of a novel series of chromenopyrazole-based GPR55 modulators in an androgen-driven model of female metabolic dysfunction

  • Ponce-Díaz, Francisco J.
  • Ruiz-Pino, Francisco
  • Herraiz, Aitor
  • Romero, Beatriz
  • Cerero-Tejero, Laura
  • García-Martín, Adela
  • Porzio-Gonzalez, Simon
  • Morales, Paula
  • Sánchez-Garrido, Miguel A.
  • Pulido, Marina R.
  • Jagerovic, Nadine
  • Tena-Sempere, Manuel
  • Muñoz, Eduardo
GPR55 is a lipid-responsive G-protein-coupled receptor implicated in metabolic regulation, but its characterization has been limited by the poor selectivity and pathway bias of classical ligands. To obtain more reliable chemical tools, we revisited the chromenopyrazole scaffold and prepared a focused series of derivatives to refine GPR55 pharmacology. In vitro profiling identified compound A as a selective lysophosphatidylinositol (LPI)-dependent positive allosteric modulator, whereas compounds 16 and 23 displayed dual orthosteric/allosteric activity. All derivatives showed clean GPR55 engagement with no detectable cannabinoid receptor type 2 activity, highlighting the improved selectivity of this scaffold., The biological relevance of these pharmacological profiles was assessed in a preclinical model of androgen-driven metabolic dysfunction reproducing key features of the metabolic phenotype observed in women with polycystic ovary syndrome (PCOS). In this model, compound A improved body weight regulation, glucose tolerance, and insulin sensitivity, while lowering serum cholesterol and triglycerides. Hepatic parameters followed a similar pattern, with reduced steatosis, macrophage infiltration, and early fibrotic remodeling. Compounds 16 and 23 produced broadly comparable benefits despite their distinct modes of GPR55 engagement, suggesting convergence on shared downstream pathways buffering metabolic stress. Hepatic GPR55 expression increased under steatotic and inflammatory conditions but normalized after treatment, supporting the potential advantage of allosteric enhancement of endogenous LPI signaling., Overall, these findings identify chromenopyrazoles as a selective GPR55-modulating scaffold with the potential to mitigate metabolic and hepatic dysfunction in models reflecting key features of PCOS., This work was supported by grants PID2023-149244NB-I00 (to MTS), PID2023-148340OB-I00 (to EM), and PID2022-1127833OB-100 (to NJ) from the Agencia Estatal de Investigación, Spain; co-funded with EU funds from FEDER Program, and EU research contract GAP-101080219 (eprObes; funded by the European Union through the Horizon Europe Framework Programme). CIBER Fisiopatología de la Obesidad y Nutrición is an initiative of Instituto de Salud Carlos III, Spain., Peer reviewed